INFLUENCE OF DOXORUBICIN ON ADHESIVE PROPERTIES OF E.COLI [PDF]
Influence ofantineoplastic drug doxorubicin and amikacin, the aminoglycoside family on adhesive activity of Escherichia coli was studied. Antimicrobialactivity(minimum inhibitory concentration-MIC) ofboth drugs against experimental strains using serial ...
O.G. Shapoval
doaj
Aminoglycosides are essential components in the available armamentarium to treat bacterial infections. The surge and rapid dissemination of resistance genes strongly reduce their efficiency, compromising public health.
Ophélie d’Udekem d’Acoz +11 more
doaj +1 more source
Satoshi Nishida, Yasuo Ono Department of Microbiology and Immunology, Teikyo University School of Medicine, Itabashi, Tokyo, Japan Introduction: The pathogenicity of fatal-outbreak Acinetobacter baumannii isolates has not been fully investigated.
Nishida S, Ono Y
doaj
Resensitization of Fluconazole-Resistant Urinary Candida spp. Isolates by Amikacin through Downregulation of Efflux Pump Genes [PDF]
EVA A. EDWARD +2 more
doaj +1 more source
The mice were divided into 9 groups for the experimental part. We have been studying clinical parameters of haemogram: the number of red blood cells, the value of ESR, hemoglobin, leukocyte formula.
O. Y. Kosilova +2 more
doaj
From Needle to Sachet: Fosfomycin Versus Amikacin for Cystoscopy Prophylaxis. [PDF]
Quadir U +9 more
europepmc +1 more source
Ceftazidime/avibactam and aztreonam combined with an aminoglycoside combat metallo-β-lactamase-producing <i>Klebsiella pneumoniae</i>. [PDF]
Karunanidhi A +10 more
europepmc +1 more source
Omadacycline as a drug candidate for Mycobacterium avium infections: in vitro insights on single and combination therapies. [PDF]
Mudde SE +7 more
europepmc +1 more source
Enhanced activity of apramycin and apramycin-based combinations against Mycobacteroides abscessus. [PDF]
Huang Y +4 more
europepmc +1 more source
Intermittent antibiotic exposure of Escherichia coli biofilms drives resistance in catheter-associated infection models. [PDF]
Yoshii Y +4 more
europepmc +1 more source

